The 1994 Veylien Henderson award of the Society of Toxicology of Canada. Mechanisms in the pathogenesis of amiodarone-induced pulmonary toxicity

被引:39
作者
Massey, TE [1 ]
Leeder, RG [1 ]
Rafeiro, E [1 ]
Brien, JF [1 ]
机构
[1] QUEENS UNIV, DEPT MED, KINGSTON, ON K7L 3N6, CANADA
关键词
amiodarone; pulmonary fibrosis; oxidative stress; pulmonary toxicity; pneumonitis;
D O I
10.1139/y95-730
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although amiodarone is a highly efficacious antidysrhythmic agent, the drug produces numerous adverse effects. The most critical of these is pulmonary toxicity because of the potential for mortality. This review examines the experimental model systems used to study amiodarone toxicity, summarizes the current state of knowledge regarding the processes involved in amiodarone-induced pulmonary toxicity (AIPT), and includes a discussion of potential future directions. Possible contributing processes to initiation of AIPT include phospholipidosis, altered calcium ion regulation, generation of reactive oxygen species, formation of an amiodarone aryl radical, and perturbation of cellular energy production. In addition, an immune response to the parent compound or to a metabolite could play a role. It is expected that elucidation of the mechanism(s) of AIPT will lead to safer antidysrhythmic agents and (or) to effective treatments for the prevention or amelioration of AIPT.
引用
收藏
页码:1675 / 1685
页数:11
相关论文
共 142 条
[1]   AMIODARONE-INDUCED PNEUMONITIS - ASSESSMENT OF RISK-FACTORS AND POSSIBLE RISK REDUCTION [J].
ADAMS, GD ;
KEHOE, R ;
LESCH, M ;
GLASSROTH, J .
CHEST, 1988, 93 (02) :254-263
[2]  
ADAMSON IY, 1994, HLTH PERSPECT, V10, P253
[3]   ENHANCED CLEARANCE OF SILICA FROM MOUSE LUNG AFTER INSTILLATION OF A LEUKOCYTE CHEMOTACTIC FACTOR [J].
ADAMSON, IYR ;
PRIEDITIS, H ;
BOWDEN, DH .
EXPERIMENTAL LUNG RESEARCH, 1994, 20 (03) :223-233
[4]   MESOTHELIAL CELL-PROLIFERATION - A NONSPECIFIC RESPONSE TO LUNG INJURY ASSOCIATED WITH FIBROSIS [J].
ADAMSON, IYR ;
BAKOWSKA, J ;
BOWDEN, DH .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 10 (03) :253-258
[5]   DRUG-INDUCED PULMONARY FIBROSIS [J].
ADAMSON, IYR .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1984, 55 (APR) :25-36
[6]   BRONCHOALVEOLAR LAVAGE CELL DATA IN AMIODARONE-ASSOCIATED PNEUMONITIS - EVALUATION IN 22 PATIENTS [J].
AKOUN, GM ;
CADRANEL, JL ;
BLANCHETTE, G ;
MILLERON, BJ ;
MAYAUD, CM .
CHEST, 1991, 99 (05) :1177-1182
[7]   AMIODARONE-INDUCED HYPERSENSITIVITY PNEUMONITIS - EVIDENCE OF AN IMMUNOLOGICAL CELL-MEDIATED MECHANISM [J].
AKOUN, GM ;
GAUTHIERRAHMAN, S ;
MILLERON, BJ ;
PERROT, JY ;
MAYAUD, CM .
CHEST, 1984, 85 (01) :133-135
[8]   AMIODARONE PULMONARY TOXICITY [J].
AKOUN, GM ;
LIOTE, HA ;
MILLERON, BJ ;
MAYAUD, CM .
CHEST, 1986, 89 (05) :768-768
[9]  
ANASTASIOUNANA M, 1982, INT J CLIN PHARM TH, V20, P524
[10]   PHARMACOKINETICS OF AMIODARONE AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
ANDREASEN, F ;
AGERBAEK, H ;
BJERREGAARD, P ;
GOTZSCHE, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (04) :293-299